[Angioneurotic edema, angioedema].
Kawamura
Yuichiro
Y
Health Administration Center, Asahikawa Medical College.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000799:Angioedema / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects; D002199:Capillary Permeability; D003174:Complement C1 Inactivator Proteins; D050718:Complement C1 Inhibitor Protein; D000075202:Contraindications; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006636:Histamine Release; D006801:Humans; D008407:Mast Cells / Q000378:metabolism; D015843:Serpins / Q000172:deficiency / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000806:Angiotensin-Converting Enzyme Inhibitors; D003174:Complement C1 Inactivator Proteins; D050718:Complement C1 Inhibitor Protein; D006634:Histamine H1 Antagonists; C469952:SERPING1 protein, human; D015843:Serpins